Evaluation of Adhesion Quality of a New Formulation of the Mylan Estradiol Transdermal System 0.025 mg/Day and Climara® Transdermal System 0.025 mg/Day
This study has been completed.
Study NCT00649896
Information provided by Mylan Pharmaceuticals
First Received: March 30, 2008
Last Updated: March 31, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
